Oxford BioDynamics is a biotechnology company that specializes in the development of epigenetic biomarkers for the diagnosis and treatment of various diseases, including cancer and autoimmune disorders. The company utilizes its proprietary EpiSwitch® platform to discover and validate these biomarkers, aiming to improve patient outcomes through personalized medicine.